Contact Us
Our ScienceHomeOur ScienceOur Covid-19 Response

In the face of COVID-19, this call is more urgent than ever, and we have aimed to leave no stone unturned as we have harnessed the full breadth and depth of our resources to address this crisis.

The Pfizer-BioNTech COVID-19 vaccine has not been approved or licensed by the Kenya Pharmacy and Poisons Board (PPB) but has been authorised for emergency use only. According to the PPB, "During a public health emergency, the PPB can use its Emergency Use Authorization (EUA) authority to allow the use of unregistered medical products, or unregistered uses of registered medical products, to diagnose, treat, or prevent serious or life-threatening diseases when certain criteria are met, including that there are no adequate, approved, and available alternatives”.

Learn more
News & MediaCareersPartnersInvestorsOur scienceAbout UsOur ProductsTerms of UseCookie and Privacy PolicyContact UsCopyright © 2002- 2022 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of the Kenya.PP-CPF-NEA-0011